Analyst Ratings for Fresenius Medical Care (FMS)
FMS Rating Summary
FMS Price Target Summary
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$23.43 (+5.7%)
* Over Last 12-Mos
Rating Score: 3.3 / 10
Percentile Rank: 30%
Avg. $ Target:
$23.43 (+5.7%)
* Over Last 12-Mos
Rating Score: 3.3 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/29/2026 | Berenberg | Harry Gillis | Downgrade | Hold (Buy) |
24.00 (34.50) |
22.69 (22.17) |
-2.29% | Details |
| 7/28/2026 | BNP Paribas Exane | Hugo Solvet | Downgrade | Underperform (Neutral) |
19.90 (N/A) |
24.59 (22.17) |
-9.84% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||



